Ubs Group Ag Qiagen N.V. Call Options Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 08, 2023	BUY	$41.91 - $50.48 $3.35 Million - $4.04 Million	80,000 Added 66.67%	200,000 $9.98 Million
Q3 2022 Nov 10, 2022	BUY	$40.9 - $50.42 $4.91 Million - $6.05 Million	120,000 New	120,000 $4.95 Million
Q3 2021 Nov 15, 2021	SELL	$46.55 - $56.83 $8.12 Million - $9.91 Million	-174,400 Reduced 97.21%	5,000 $258,000
Q4 2020 Feb 11, 2021	BUY	$46.09 - $54.74 $5.96 Million - $7.08 Million	129,400 Added 258.8%	179,400 $9.48 Million
Q1 2020 May 01, 2020	SELL	$33.17 - $41.6 $8.92 Million - $11.2 Million	-269,046 Reduced 84.33%	50,000 $2.08 Million
Q4 2018 Feb 14, 2019	BUY	$32.65 - $37.95 $10.4 Million - $12.1 Million	319,046 New	319,046 $11 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.